Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation.

Abstract:

:Stroke is the second leading cause of mortality world-wide and is well suited for prevention because it has a high prevalence, high burden of economic cost, well-defined modifiable risk factors, and effective prevention measures. Atherosclerosis is one of the major mechanisms of ischemic stroke, but the apparent differences in risk factors for intra- and extracranial atherosclerosis are unclear and the mechanisms that underlie strokes in patients with intracranial atherosclerosis are not well known. Consequently, patients with intracranial stenosis receive the same treatment as those with carotid -atherosclerosis. Several novel substances have emerged recently as risk factors for atherosclerosis. Specifically, it has recently been suggested that both the metabolic syndrome, which refers to a constellation of metabolic risk factors that are linked to insulin resistance, and vascular inflammation are associated with increased risk of coronary heart disease and stroke. The results of the studies reviewed here suggest that these factors play a differential role in the development of atherosclerotic stroke between the intra- and extracranial arterial systems.

journal_name

Curr Atheroscler Rep

authors

Bang OY

doi

10.1007/s11883-006-0012-1

subject

Has Abstract

pub_date

2006-07-01 00:00:00

pages

330-6

issue

4

eissn

1523-3804

issn

1534-6242

journal_volume

8

pub_type

杂志文章,评审
  • Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

    abstract::The original version of this article contains errors in Table 3. "At least 1 project/publication in the year" and "> 1 publication per year" have been switched under the titles of "Clinical Track" and "Physician-Scientist track". ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,已发布勘误

    doi:10.1007/s11883-018-0743-9

    authors: Saeed A,Dabhadkar K,Virani SS,Jones PH,Ballantyne CM,Nambi V

    更新日期:2018-06-19 00:00:00

  • Remnant lipoproteins and atherosclerosis.

    abstract::A recently developed assay for quantification of remnant-like particle cholesterol has provided considerable evidence that reinforces the concept that elevated levels of plasma remnants are associated with increased cardiovascular disease in different populations and distinct patient groups. In this review, we provide...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-005-0037-x

    authors: Twickler T,Dallinga-Thie GM,Chapman MJ,Cohn JS

    更新日期:2005-03-01 00:00:00

  • The complex genetic basis of plasma triglycerides.

    abstract::Demonstration of a direct relationship between plasma triglyceride (TG) concentration and atherosclerosis has proven difficult due to confounding variables that accompany elevated plasma TG, such as other dyslipidemias, obesity, and type 2 diabetes. However, human genetic studies have provided evidence suggesting a ca...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0243-2

    authors: Johansen CT,Hegele RA

    更新日期:2012-06-01 00:00:00

  • Mobile Stroke Units - Cost-Effective or Just an Expensive Hype?

    abstract:PURPOSE OF REVIEW:Acute stroke is a treatable disease. Nevertheless, only a minority of patients obtain guideline-adjusted therapy. One major reason is the small time window in which therapies have to be administered in order to reverse or mitigate brain injury and prevent disability. The Mobile Stroke Unit (MSU) conce...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-018-0751-9

    authors: Walter S,Grunwald IQ,Helwig SA,Ragoschke-Schumm A,Kettner M,Fousse M,Lesmeister M,Fassbender K

    更新日期:2018-08-29 00:00:00

  • Mouse models of lipodystrophy.

    abstract::Lipodystrophies are a group of heterogeneous diseases characterized by the loss of adipose tissue and by abnormalities of carbohydrate and lipid metabolism, including insulin resistance, diabetes, and hyperlipidemia. In this review, we describe several mouse models that recapitulate various aspects of the lipodystroph...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-000-0077-1

    authors: Reue K,Péterfy M

    更新日期:2000-09-01 00:00:00

  • Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?

    abstract::In the USA, 69 % of adults are either overweight or obese and 35 % are obese. Obesity is associated with an increased incidence of various cardiovascular disorders. Obesity is a risk marker for cardiovascular disease, in that it is associated with a much higher prevalence of comorbidities such as diabetes, hypertensio...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0575-4

    authors: Mandviwala T,Khalid U,Deswal A

    更新日期:2016-05-01 00:00:00

  • FXR agonists as therapeutic agents for non-alcoholic fatty liver disease.

    abstract::Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and a risk factor for both cardiovascular and hepatic related morbidity and mortality. The increasing prevalence of this disease requires novel therapeutic approaches to prevent disease progression. Farnesoid X receptors a...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-015-0500-2

    authors: Carr RM,Reid AE

    更新日期:2015-04-01 00:00:00

  • Role of Coronary Calcium Score to Identify Candidates for ASCVD Prevention.

    abstract:PURPOSE OF REVIEW:In this review, we describe the mechanism behind coronary artery calcification formation and detection, as well as its implication in cardiovascular disease (CVD) risk stratification, intervention, and prognosis in asymptomatic individuals. RECENT FINDINGS:Multiple cohort and population studies have ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-019-0812-8

    authors: Nguyen HL,Liu J,Del Castillo M,Shah T

    更新日期:2019-11-21 00:00:00

  • Impact of circulating esterified eicosanoids and other oxylipins on endothelial function.

    abstract::Eicosanoids, including epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and other oxylipins derived from polyunsaturated fatty acids, have emerging roles in endothelial inflammation and subsequent atherosclerosis. Unlike eicosanoids in the prostanoid series, they are known to be esterified in cell lipids such...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0061-3

    authors: Shearer GC,Newman JW

    更新日期:2009-11-01 00:00:00

  • Hormone replacement therapy trials: an update.

    abstract::Recent randomized trials of hormone replacement therapy (HRT) in postmenopausal women are not consistent with the decrease in cardiovascular risk seen in observational studies of hormone therapy users compared with nonusers. Emerging evidence indicates that HRT use in some women with established coronary heart disease...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章

    doi:10.1007/s11883-002-0040-4

    authors: Duvernoy CS,Mosca L

    更新日期:2002-03-01 00:00:00

  • Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately.

    abstract::Atrial fibrillation (AF) is the most common cardiac arrhythmia in humans. One of its important features is the tendency to become more persistent over time, even in the absence of underlying progressive heart disease. Conversion and maintenance of sinus rhythm by pharmacological or electrical methods become increasing...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-017-0638-1

    authors: Piña PG,Chicos AB

    更新日期:2017-01-01 00:00:00

  • Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress.

    abstract::Various lifestyle factors have been associated with increasing the risk of stroke. These include lack of exercise, alcohol, diet, obesity, smoking, drug use, and stress. Guidelines endorsed by the Centers for Disease Control and Prevention and the National Institutes of Health recommend that Americans should exercise ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-000-0111-3

    authors: Boden-Albala B,Sacco RL

    更新日期:2000-03-01 00:00:00

  • Nicotinic acid: a new look at an old drug.

    abstract::Dyslipidemia is central to the process of atherosclerosis. Modification of the lipid profile by diet, exercise, or pharmacologic therapy has been demonstrated to reduce the risk from atherosclerosis in clinical studies in primary and secondary prevention. Nicotinic acid has been in clinical use for over 50 years. The ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0014-x

    authors: Farmer JA

    更新日期:2009-03-01 00:00:00

  • The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses.

    abstract::The cardioprotective effects of omega-3 fatty acids (n-3 FAs) are well known, but the role that the n-6 FAs play in coronary heart disease is unclear. These two classes of essential FAs compete for a number of enzyme systems, and their metabolites can powerfully influence (often in different directions) inflammatory r...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-006-0019-7

    authors: Harris WS

    更新日期:2006-11-01 00:00:00

  • The ligand/RAGE axis: lighting the fuse and igniting vascular stress.

    abstract::Vascular inflammation contributes critically to the initiation and progression of atherosclerosis. These processes are accelerated in hyperglycemia and play key roles in the increased incidence and severity of myocardial infarction and stroke observed in diabetes. Evidence suggests that the ligands of the receptor for...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-006-0078-9

    authors: Yan SF,Naka Y,Hudson BI,Herold K,Yan SD,Ramasamy R,Schmidt AM

    更新日期:2006-05-01 00:00:00

  • Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?

    abstract::Numerous retrospective and prospective observational studies support an association between elevated homocysteine and increased risk for myocardial infarction, stroke, and peripheral vascular disease. Although folic acid therapy substantially reduces homocysteine levels, recent large, randomized controlled trials fail...

    journal_title:Current atherosclerosis reports

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s11883-007-0048-x

    authors: Maron BA,Loscalzo J

    更新日期:2007-11-01 00:00:00

  • Sex-Based Considerations in the Evaluation of Chest Pain and Management of Obstructive Coronary Artery Disease.

    abstract:PURPOSE OF REVIEW:Coronary artery disease (CAD) is a major cause of morbidity and mortality globally and poses a threat to both men and women across their lifespans. There is accumulating evidence to support that CAD may present differently in women and men, ranging from the clinical presentation, diagnosis, and manage...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00855-7

    authors: Madan N,Gajo E,Sanghani RM,Volgman AS

    更新日期:2020-06-23 00:00:00

  • Modulation of the renin-angiotensin-aldosterone system in heart failure.

    abstract::The renin-angiotensin-aldosterone system (RAAS) is well-established and continues to be pursued as a therapeutic target in the treatment of heart failure, predominantly due to the success of agents that block RAAS in clinical trials of systolic heart failure. The optimal treatment of heart failure patients with preser...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0403-7

    authors: George J,Struthers AD,Lang CC

    更新日期:2014-04-01 00:00:00

  • Antiatherothrombotic effects of dipeptidyl peptidase inhibitors.

    abstract::Atherothrombotic cardiovascular events are a leading cause of morbidity and mortality in patients with type 2 diabetes (T2D). A number of factors beyond hyperglycemia contribute to this increased risk of cardiovascular events in T2D, including elevated blood pressure, dyslipidemia, inflammation, endothelial dysfunctio...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0408-2

    authors: Cameron-Vendrig A,Mundil D,Husain M

    更新日期:2014-05-01 00:00:00

  • Low-density lipoprotein reduction in high-risk patients: how low do you go?

    abstract::Cardiovascular disease and its clinical sequelae remain the leading causes of morbidity and mortality in many regions of the world. Dyslipidemia is a critical risk factor to intercept in both the primary and secondary prevention of acute cardiovascular events. The prospective, placebo-controlled clinical trials conduc...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-004-0045-2

    authors: Toth PP

    更新日期:2004-09-01 00:00:00

  • Clinical syndromes and management of intracerebral hemorrhage.

    abstract::Spontaneous intracerebral hemorrhage (ICH) is a devastating disease with high morbidity and mortality. Acutely, ICH is associated with a sudden surge in intracranial pressure (ICP), as the volume of hematoma increases the pressure in the closed head, leading to non-specific symptoms of ICP: headache, nausea, vomiting,...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0251-2

    authors: Ko SB,Choi HA,Lee K

    更新日期:2012-08-01 00:00:00

  • High-density lipoprotein: antioxidant and anti-inflammatory properties.

    abstract::The ability of high-density lipoprotein (HDL) to promote cholesterol efflux is an important component of its ability to protect against cardiovascular disease. In addition, the anti-inflammatory properties of HDL are important as well. As part of the innate immune system, HDL appears to have evolved to increase inflam...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-007-0026-3

    authors: Navab M,Yu R,Gharavi N,Huang W,Ezra N,Lotfizadeh A,Anantharamaiah GM,Alipour N,Van Lenten BJ,Reddy ST,Marelli D

    更新日期:2007-09-01 00:00:00

  • Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.

    abstract:PURPOSE OF REVIEW:For over 20 years, the Women's Ischemia Syndrome Evaluation (WISE), a program sponsored by the National Heart, Lung, and Blood Institute, has explored diverse and important aspects of ischemic heart disease in women. RECENT FINDINGS:Women with symptoms and signs of ischemia but no significant epicard...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00852-w

    authors: Barsky L,Merz CNB,Wei J,Shufelt C,Handberg E,Pepine C,Rutledge T,Reis S,Doyle M,Rogers W,Shaw L,Sopko G

    更新日期:2020-06-18 00:00:00

  • Oxidative stress and atherosclerosis.

    abstract::Understanding of the pathophysiology of atherosclerosis can provide new strategies for the prevention and treatment of patients with this common disease. Clinical, epidemiologic, and basic molecular science studies have identified oxidative stress as a factor contributing to the development and progression of atherosc...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-005-0013-5

    authors: Schulze PC,Lee RT

    更新日期:2005-05-01 00:00:00

  • Current and future use of intravenous thrombolysis for acute ischemic stroke.

    abstract::Stroke is a common and disabling condition. Intravenous tissue plasminogen activator (tPA) administered within 3 h of symptom onset is the standard therapy for eligible patients with acute ischemic stroke. Unfortunately, because of the time limitation, very few patients with ischemic stroke actually receive this treat...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-010-0121-8

    authors: Elijovich L,Chong JY

    更新日期:2010-09-01 00:00:00

  • Erectile dysfunction and atherosclerosis.

    abstract::Erectile dysfunction (ED) is a common problem in the United States, with estimates that 30 million men suffer with some degree of ED. Although causes include psychogenic, organic, and mixed forms, in middle-aged and older men one of the most common causes is vascular disease. Endothelial dysfunction, even without defi...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-002-0078-3

    authors: Kloner RA,Speakman M

    更新日期:2002-09-01 00:00:00

  • Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).

    abstract::Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is an enzyme which binds to oxidized LDL and has a pro-inflammatory role in the pathogenesis of atherosclerosis. The Lp-PLA(2) Studies Collaboration showed the relationship between Lp-PLA(2) levels and activity with coronary heart disease and ischemic stroke. Level...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-011-0201-4

    authors: Wong CK,White HD

    更新日期:2011-12-01 00:00:00

  • The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.

    abstract:PURPOSE OF REVIEW:We aimed to summarize recent guidelines, position papers, and high-quality clinical research relating the use of nutraceuticals in the management of individuals at high risk of atherosclerotic cardiovascular disease. RECENT FINDINGS:It is essential that individuals at high risk of cardiovascular dise...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00887-z

    authors: Penson PE,Banach M

    更新日期:2020-09-18 00:00:00

  • Advances in Coronary No-Reflow Phenomenon-a Contemporary Review.

    abstract:PURPOSE OF REVIEW:Coronary artery no-reflow phenomenon is an incidental outcome of percutaneous coronary intervention in patients presenting with acute myocardial infarction. Despite advances in pharmacologic and non-pharmacologic therapies, coronary no-reflow phenomenon occurs more commonly than desired. It often resu...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章

    doi:10.1007/s11883-018-0747-5

    authors: Karimianpour A,Maran A

    更新日期:2018-07-05 00:00:00

  • Stroke and cognition.

    abstract::Several studies confirm cognitive impairment and dementia to be increased after stroke in the elderly. Although not necessarily involving memory deficits, the frequency of cognitive impairments may occur in up to 30% of stroke survivors at 3 months. This impairment may be confounded by preexisting cognitive decline or...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-001-0028-5

    authors: Kalaria RN,Ballard C

    更新日期:2001-07-01 00:00:00